Approaches for adolescents with an affected family member with schizophrenia

Current Psychiatry Reports

Volumn 6, Issue 4, 2004, Pages 296-302

  Diwadkar, Vaibhav A ^b   Prasad, Konasale M ^b   Keshavan, Matcheri S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; NEU DIFFERENTIATION FACTOR;

ADOLESCENT; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; CLINICAL FEATURE; COGNITIVE DEFECT; FAMILY; GENE IDENTIFICATION; GENETIC PREDISPOSITION; GENETIC SCREENING; HIGH RISK POPULATION; HUMAN; MOLECULAR GENETICS; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION DISTRIBUTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA;

EID: 4444313561     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-004-0080-2     Document Type: Review

References (72)

1. Carpenter WT Jr., Buchanan RW: Schizophrenia. N Engl J Med 1994, 330:681-690.
2. Schultz SK, Andreasen NC: Schizophrenia. Lancet 1999, 353:1425-1430.
3. Lewis DA, Levitt P: Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 2002, 25:409-432.
4. Murray CJL, Lopez AD: The Global Burden of Disease: Global Burden of Disease and Injury Series, vol 1. Boston: Harvard School of Public Health; 1996.
5. McGorry PD: "A stitch in time"...the scope for preventive strategies in early psychosis. Eur Arch Psychiatry Clin Neurosci 1998, 248:22-31.
6. Diwadkar VA, Keshavan MS: Newer techniques in magnetic resonance imaging and their potential for neuropsychiatric research. J Psychosom Res 2002, 53:677-685.
7. McCarley RW: MRI anatomy of schizophrenia. Biol Psychiatry 1999, 45:1099-1119.
8. Shenton ME: A review of MRI findings in schizophrenia. Schizophr Res 2001, 49:1-52.
9. Callicott JH: An expanded role for functional neuroimaging in schizophrenia. Curr Opin Neurobiol 2003, 13:256-260.
10. Marenco S, Weinberger DR: The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol 2001, 12:501-527.
11. Malmberg A: Premorbid adjustment and personality in people with schizophrenia. Br J Psychiatry 1998, 172:308-313.
12. Weinberger DR: The biological basis of schizophrenia: new directions. J Clin Psychiatry 1997, 58:22-27.
13. Feinberg I: Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1982, 17:319-334.
14. Keshavan MS, Anderson S, Pettegrew JW: Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? J Psychiatr Res 1994, 28:239-265.
15. Murray RM, Fearon P: The developmental 'risk factor' model of schizophrenia. J Psychiatr Res 1999, 33:497-499.
16. Chua SE, Murray RM: The neurodevelopmental theory of schizophrenia: evidence concerning structure and neuropsychology. Ann Med 1996, 28:547-555.
17. Rakic PT: The importance of being well placed and having the right connections. Ann N Y Acad Sci 1999, 882:90-106.
18. Rubenstein JL, Rakic P: Genetic control of cortical development. Cereb Cortex 1999, 9:521-523.
19. Case R: The role of the frontal lobes in the regulation of cognitive development. Brain Cogn 1992, 20:51-73.
20. Gottesman II: Schizophrenia Genesis: The Origins of Madness. New York: WH Freeman and Company, 1991.
21. Erlenmeyer-Kimling L: The New York High-Risk Project. Arch Gen Psychiatry 1995, 10:857-865.
22. Gottesman II, Shields J: Schizophrenia: The Epigenetic Puzzle. New York: Cambridge University Press; 1982.
23. McGuffin P: Twin concordance for operationally defined schizophrenia: confirmation of familiality and heritability. Arch Gen Psychiatry 1984, 41:541-545.
24. Kendler KS: Hierarchy and heritability: the role of diagnosis and modeling in psychiatric genetics. Am J Psychiatry 2002, 159:515-518.
25. Kety SS: Mental illness in the biological and adoptive families of adopted individuals who have become schizophrenic: a preliminary report based on psychiatric interviews. Proc Annu Meet Am Psychopathol Assoc 1975, 63:147-165.
26. Kety SS: Mental illness in the biological and adoptive families of adopted individuals who have become schizophrenic. Behav Genet 1976, 6:219-225.
27. Fish B: Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect. A review and replication analysis of pandysmaturation in the Jerusalem infant development study. Arch Gen Psychiatry 1992, 49:221-235.
28. McNeil TF: Neuromotor deviation in offspring of psychotic mothers: a selective developmental deficiency in two groups of children at heightened psychiatric risk? J Psychiatr Res 1993, 27:39-54.
29. Marcus J: Children at risk for schizophrenia: the Jerusalem Infant Development Study, II: neurobehavioral deficits at school age. Arch Gen Psychiatry 1993, 50:797-809.
30. Erlenmeyer-Kimling L: The New York High-Risk Project: psychoses and cluster A personality disorders in offspring of schizophrenic parents at 23 years of follow-up. Arch Gen Psychiatry 1995, 52:857-865.
31. Mirsky AF: Overview and summary: twenty-five year follow-up of high-risk children. Schizophr Bull 1995, 21:227-239.
32. Mednick SA, Parnas J, Schulsinger F: The Copenhagen High-Risk Project 1962-1986. Schizophr Bull 1987, 13:485-495.
33. Johnstone EC: The Edinburgh High Risk Study: current status and future prospects. World Psychiatry 2003, 2:45-49.
34. Kremen WS: Neuropsychological risk indicators for schizophrenia: a review of family studies. Schizophr Bull 1994, 20:103-119.
35. Cornblatt BA, Keilp JG: Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull 1994, 20:31-46.
36. Erlenmeyer-Kimling, L: Neurobehavioral deficits in offspring of schizophrenic parents: liability indicators and predictors of illness. Am J Med Genet 2000, 97:65-71.
37. Michie PT: Phenotypic markers as risk factors in schizophrenia: neurocognitive functions. Aust N Z J Psychiatry 2000, 34(suppl):S74-S85.
38. Keshavan MS: Psychosis proneness and ADHD in young relatives of schizophrenia patients. Schizophr Res 2002, 59:85-92.
39. Lawrie SM: Premorbid structural abnormalities in schizophrenia. In Neurodevelopment and Schizophrenia Edited by Keshavan MS, Kennedy JL, Murray RM. London: Cambridge University Press; 2004:in press.
40. Keshavan MS: Decreased left amygdala and hippocampal volumes in young offspring at risk for schizophrenia. Schizophr Res 2002, 58:173-183.
41. Rajarethinam RP: Reduction of superior temporal gyrus volume in young offspring of patients with schizophrenia. Am J Psychiatry 2004, in press.
42. Diwadkar VA: Cognitive impairments and structural MRI abnormalities in schizotypal first-degree relatives of schizophrenia patients. Biol Psychiatry 2003, 53(suppl):500.
43. Seidman LJ: Left hippocampal volume as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric study of nonpsychotic first-degree relatives. Arch Gen Psychiatry 2002, 59:839-849.
44. Pantelis C: Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003, 361:281-288.
45. Keshavan MS, Stanley JA, Pettegrew JW: Magnetic resonance spectroscopy in schizophrenia: methodogical issues and findings, part II. Biol Psychiatry 2000, 48:369-380.
46. Keshavan MS: Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: preliminary studies. Prog Neuropsychopharmacol Biol Psychiatry 1997, 21:1285-1295.
47. Callicott JH: Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype. Biol Psychiatry 1998, 44:941-950.
48. Keshavan MS: Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study. Mol Psychiatry 2003, 8:316-323.
49. Callicott JH: Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry 2003, 160:709-719.
50. Keshavan MS: A preliminary functional magnetic resonance imaging study in offspring of schizophrenic parents. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:1143-1149.
51. Raemaekers M: Neuronal substrate of the saccadic inhibition deficit in schizophrenia investigated with 3-dimensional event-related functional magnetic resonance imaging. Arch Gen Psychiatry 2002, 59:313-320.
52. O'Driscoll GA: Neural correlates of eye tracking deficits in first-degree relatives of schizophrenic patients: a positron emission tomography study. Arch Gen Psychiatry 1999, 56:1127-1134.
53. Egan MF: Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiatry 2001, 50:98-107.
54. Levy DL: Eye tracking and schizophrenia: a selective review. Schizophr Bull 1994, 20:47-62.
55. Ross RG: Early expression of a pathophysiological feature of schizophrenia: saccadic intrusions into smooth-pursuit eye movements in school-age children vulnerable to schizophrenia. J Am Acad Child Adolesc Psychiatry 2003, 42:468-476.
56. Diwadkar VA: Memory guided saccade abnormalities in young offspring and siblings at risk for schizophrenia. CNS Spectrums 2001, 6:899-903.
57. Friedman D, Squires-Wheeler E: Event-related potentials (ERPs) as indicators for risk for schizophrenia. Schizophr Bull 1994, 20:63-74.
58. Schreiber H: Prolonged latencies of the N2 and P3 of the auditory event-related potential in children at risk for schizophrenia: a preliminary report. Eur Arch Psychiatry Neurol Sci 1989, 238:185-188.
59. Dykes KL: Adult third ventricle width and infant behavioral arousal in groups at high and low risk for schizophrenia. Schizophr Res 1992, 7:13-18.
60. Hollister JM: Impaired autonomic nervous system-habituation in those at genetic risk for schizophrenia. Arch Gen Psychiatry 1994, 51:552-558.
61. Chumakov I: Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 2002, 99:13675-13680.
62. Stefansson H: Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002, 71:877-892.
63. Egan MF: Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001, 98:6917-6922.
64. Prasad KMR: RGS4 gene polymorphism, cognition and in vivo neurobiology in first episode schizophrenia. Schizophr Res 2004, 67(suppl):28.
65. Carter JW: A multivariate prediction model of schizophrenia. Schizophr Bull 2002, 28:649-682.
66. Tienari P: Genetic boundaries of the schizophrenia spectrum: evidence from the Finnish Adoptive Family Study of Schizophrenia. Am J Psychiatry 2003, 160:1587-1594.
67. Callicott JH: Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 2000, 10:1078-1092.
68. Keshavan MS: Investigating risk for schizophrenia: how genetic high risk approaches can inform prodromal research. ACNP Scientific Abstract 2003.
69. Theberge J: Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry 2002, 159:1944-1946.
70. Harrison PJ, Owen MJ: Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 2003, 361:417-419.
71. Prasad KMR: RGS4 gene polymorphism, cognition and in vivo neurobiology in first episode schizophrenia. Schizophr Res 2004, 67(suppl):28.
72. McGorry PD, Yung AR, Phillips LJ: The "close-in" or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bull 2003, 29:771-790.